Skip to content
GLP-1 Desk
Menu
Dispatch #54

GOAL.MD

GOAL.MD is a St. Louis-based telehealth platform offering compounded semaglutide alongside brand-name bridges to Ozempic, Wegovy, and Zepbound. Its standout is a manual-renewal model — no auto-billing

Visit GOAL.MDAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$179/mo
Tirzepatide
$249/mo (starting dose, compounded)
Coverage
All 50 states
Brand-name
Yes

Weigh GOAL.MD against the full ranked field on the best semaglutide providers board, or line it up against its closest alternatives. Or go one-on-one: GOAL.MD vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency94/100
State access86/100
Molecule range90/100
Onboarding speed70/100
Support responsiveness72/100
Licensing & trust41/100

What the Desk likes

  • Transparent dose-tiered pricing on brand pens
  • LegitScript Certified
  • Manual-renewal model — no surprise auto-billing
  • Free nutrition coach included
  • BBB A+ rating since 2021

Where points come off

  • No named compounding pharmacy partner
  • Co-founder and chief physician has a 2016 federal guilty plea for distributing misbranded HGH and a (reinstated) license revocation
  • No URAC or PCAB pharmacy accreditation

The Desk's briefing — B−

Best for: Readers who want manual-renewal billing with dose-tiered brand-name pricing transparency.

GOAL.MD ranks #54 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (24)

Pricing and verification reflect GOAL.MD's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on GOAL.MD's site. Not medical advice; see our disclosure.

← Back to The Desk